Ertapenem susceptibility in septicaemia due to extended spectrum beta lactamase (ESBL) organisms in teaching medical college and hospital covering rural community

ESBL producing clinical isolates of gram negative organisms are major burden in hospital as well as in the community. These organisms are the causative agent for septicemia. Carbapenem group (Imipenem and Ertapenem) are the drug of choice for treating such infections. Recently increased incidences of resistance to Imipenem were reported, that makes the management of sepsis difficult.